Funded Biotechnology Startups in India
Across the 47 most recent biotechnology funding entries in India with disclosed amounts, the largest round is Fingpay’s $267M (2020-04-02).
Across the 47 most recent biotechnology funding entries in India with disclosed amounts, the largest round is Fingpay’s $267M (2020-04-02). That figure dwarfs the rest of the disclosed rounds: the next-highest disclosed amounts visible here are MedGenome’s $50M (2022-08-30) and Krimanshi’s $50M (2020-10-19), placing most other disclosed rounds in the low single-digit millions or below. The smallest disclosed amount is Biome Technologies’ $20K (2023-06-20), making the disclosed range unusually wide.
Timing clusters and stage mix are also noticeable. Rounds span 2020-04-02 through 2026-06-11 (most recent: 4baseCare $4M on 2026-06-11), with several June 2026 entries on 2026-06-11 (4baseCare $4M and Biodimension Technology $840K). City concentration appears strongest around Bengaluru, Karnataka, which hosts multiple companies across different stages (e.g., 4baseCare; immunitoAI; Eyestem; BrainSightAI in multiple years), while stage labels show many “Series Unknown” classifications (9 rows) and “undisclosed” amounts (3 rows).
Most recent rounds
47 shownRelated listings
Frequently asked
What stands out most in disclosed round sizes, and how big is the gap versus the rest of the list?
Fingpay’s $267M (2020-04-02) is the only disclosed amount above $50M in these rows, with the next-highest disclosed rounds at $50M for both MedGenome (2022-08-30) and Krimanshi (2020-10-19). At the low end, Biome Technologies’ $20K (2023-06-20) sits far below even the next-smallest disclosed values like $83M’s absence—indicating a wide disclosed-range spread.
Are there temporal clusters where multiple rounds close close together?
Yes. On 2026-06-11 there are two disclosed entries: 4baseCare ($4M) and Biodimension Technology ($840K). Another tight two-day cluster appears in early 2026: Pandorum Technologies closes 2026-02-09 ($18M) and PlasmaGen Biosciences closes 2025-12-22 ($17M), while 2025 also contains several closely spaced rounds (e.g., immunitoAI on 2025-11-29 $6M and Eyestem on 2025-08-11 $10M).
Which cities appear most frequently, suggesting a geographic hub pattern in this dataset?
Bengaluru, Karnataka is the most recurrent location, spanning multiple companies and stages across years—for example 4baseCare (Series B, 2026-06-11 $4M), immunitoAI (Series A, 2025-11-29 $6M), Eyestem (Series B, 2025-08-11 $10M), and algorithmically another BrainSightAI listing (Seed on 2025-01-08 $5M, plus a separate 2023-07-10 entry with $120K).
How dominant is “Series Unknown” or undisclosed funding versus explicitly labeled stages?
“Series Unknown” appears 9 times (e.g., Regeno Ventures on 2026-01-22; PlasmaGen Biosciences on 2025-12-22; Transcell Biologics on 2024-09-09), while “undisclosed” amounts appear 3 times (e.g., Regeno Ventures 2026-01-22; Human Biogenesis on 2024-09-12; Neuphony on 2023-06-20). This means many of the most recent and mid-window entries are harder to compare by stage because the round label or amount is missing.
Are there outliers beyond size, such as different round labeling categories?
Yes—Krimanshi (2020-10-19) is a notable size outlier at $50M with an unlabeled stage category (blank), while multiple very large rounds are tied to non-standard labels later in the window, such as Molbio Diagnostics’ $83M (2022-09-26, “Venture - Series Unknown”) and Fingpay’s $267M (2020-04-02, blank). These label differences matter when mapping which parts of the market are raising through conventional named rounds versus other deal structures.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.